Product Description
Sunitinib is a potent inhibitor of CSF-1 receptor kinase in an enzyme assay, with an IC₅₀ of 7 nM, and inhibits receptor phosphorylation in a cellular assay with an IC₅₀ of 61 nM. Sunitinib inhibits SCF-induced phosphotyrosine levels on KIT (IC₅₀ = 1 - 10 nM) and reduced SCF-stimulated ERK1/2 phosphorylation with an IC₅₀ value consistent with that for inhibition of KIT phosphotyrosine levels. Sunitinib also inhibited SCF-stimulated proliferation in NCI-H526 cells (IC₅₀ = 2 nM).
Sunitinib is a potent inhibitor of CSF-1 receptor kinase in an enzyme assay, with an IC₅₀ of 7 nM, and inhibits receptor phosphorylation in a cellular assay with an IC₅₀ of 61 nM.
Biovision | 1611 | Sunitinib Malate (Sutent) DataSheet
Alternate Name/Synonyms: Sunitinib Maleate, SU-11248, Sutent, PHA-290940AD, PNU-290940AD
Appearance: Yellow-orange powder
Formulation: N/A
CAS Number: 341031-54-7
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₂H₂₇FN₄O₂.C₄H₆O₅
Molecular Weight: 532.56
Cell-Permeable?: Yes
Purity: ≥99% by HPLC
Solubilities: DMSO (40 mg/ml)
Handling: Protect from air and moisture
Country of Origin: USA
Tag Line: A CSF-1 receptor kinase inhibitor
MDL Number: MFCD08282795
PubChem CID: 6456015
SMILES: CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(= O)O
InChi: InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14 (20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8, 11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8, 9)/b17-12-;/t;2-/m.0/s1
InChi Key: LBWFXVZLPYTWQI-IPOVEDGCSA-N